EMBC
Embecta Corp.
$3.64
+1.11%
2026-05-08
About Embecta Corp.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Key Fundamentals
P/E Ratio
1.90
Forward P/E
1.79
EPS (TTM)
$1.89
Revenue Growth (YoY)
-14.4%
Profit Margin
10.7%
Dividend Yield
12.7%
Beta
1.05
Market Cap
$213.0M
Avg Volume (10D)
3.6M
Recent Breakout Signals
No recent breakout signals detected for EMBC.
Recent Price Range (60 Days)
60D High
$10.90
60D Low
$3.45
Avg Volume
1.4M
Latest Close
$3.64
Get breakout alerts for EMBC
Sign up for Breakout Scanner to receive daily notifications when EMBC triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Embecta Corp. (EMBC) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors EMBC daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. EMBC operates in the Healthcare sector within the Medical Instruments & Supplies industry. Data is provided for informational purposes only and does not constitute financial advice.